Taiwan · Delayed Price · Currency is TWD Onyx Healthcare Statistics
Total Valuation
Onyx Healthcare has a market cap or net worth of TWD 3.97 billion. The enterprise value is 3.88 billion.
| Market Cap | 3.97B |
| Enterprise Value | 3.88B |
Important Dates
The next estimated earnings date is Friday, May 8, 2026.
| Earnings Date | May 8, 2026 |
| Ex-Dividend Date | Jul 3, 2025 |
Share Statistics
Onyx Healthcare has 39.07 million shares outstanding. The number of shares has increased by 0.45% in one year.
| Current Share Class | 39.07M |
| Shares Outstanding | 39.07M |
| Shares Change (YoY) | +0.45% |
| Shares Change (QoQ) | +0.78% |
| Owned by Insiders (%) | 12.04% |
| Owned by Institutions (%) | 0.02% |
| Float | 12.30M |
Valuation Ratios
The trailing PE ratio is 35.37.
| PE Ratio | 35.37 |
| Forward PE | n/a |
| PS Ratio | 3.02 |
| PB Ratio | 2.53 |
| P/TBV Ratio | 2.53 |
| P/FCF Ratio | 26.89 |
| P/OCF Ratio | 24.51 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 27.20, with an EV/FCF ratio of 26.29.
| EV / Earnings | 34.58 |
| EV / Sales | 2.95 |
| EV / EBITDA | 27.20 |
| EV / EBIT | 32.11 |
| EV / FCF | 26.29 |
Financial Position
The company has a current ratio of 2.17, with a Debt / Equity ratio of 0.19.
| Current Ratio | 2.17 |
| Quick Ratio | 1.45 |
| Debt / Equity | 0.19 |
| Debt / EBITDA | 3.95 |
| Debt / FCF | 1.99 |
| Interest Coverage | 11.17 |
Financial Efficiency
Return on equity (ROE) is 7.15% and return on invested capital (ROIC) is 3.25%.
| Return on Equity (ROE) | 7.15% |
| Return on Assets (ROA) | 1.53% |
| Return on Invested Capital (ROIC) | 3.25% |
| Return on Capital Employed (ROCE) | 2.95% |
| Weighted Average Cost of Capital (WACC) | 5.32% |
| Revenue Per Employee | 10.94M |
| Profits Per Employee | 934,442 |
| Employee Count | 120 |
| Asset Turnover | 0.62 |
| Inventory Turnover | 3.35 |
Taxes
In the past 12 months, Onyx Healthcare has paid 10.21 million in taxes.
| Income Tax | 10.21M |
| Effective Tax Rate | 8.37% |
Stock Price Statistics
The stock price has decreased by -18.80% in the last 52 weeks. The beta is 0.25, so Onyx Healthcare's price volatility has been lower than the market average.
| Beta (5Y) | 0.25 |
| 52-Week Price Change | -18.80% |
| 50-Day Moving Average | 98.84 |
| 200-Day Moving Average | 112.33 |
| Relative Strength Index (RSI) | 58.16 |
| Average Volume (20 Days) | 43,477 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Onyx Healthcare had revenue of TWD 1.31 billion and earned 112.13 million in profits. Earnings per share was 2.87.
| Revenue | 1.31B |
| Gross Profit | 434.02M |
| Operating Income | 52.24M |
| Pretax Income | 121.91M |
| Net Income | 112.13M |
| EBITDA | 67.57M |
| EBIT | 52.24M |
| Earnings Per Share (EPS) | 2.87 |
Balance Sheet
The company has 380.83 million in cash and 292.84 million in debt, with a net cash position of 87.99 million or 2.25 per share.
| Cash & Cash Equivalents | 380.83M |
| Total Debt | 292.84M |
| Net Cash | 87.99M |
| Net Cash Per Share | 2.25 |
| Equity (Book Value) | 1.57B |
| Book Value Per Share | 40.19 |
| Working Capital | 449.79M |
Cash Flow
In the last 12 months, operating cash flow was 161.78 million and capital expenditures -14.29 million, giving a free cash flow of 147.49 million.
| Operating Cash Flow | 161.78M |
| Capital Expenditures | -14.29M |
| Depreciation & Amortization | 15.33M |
| Net Borrowing | 33.06M |
| Free Cash Flow | 147.49M |
| FCF Per Share | 3.78 |
Margins
Gross margin is 33.05%, with operating and profit margins of 3.98% and 8.54%.
| Gross Margin | 33.05% |
| Operating Margin | 3.98% |
| Pretax Margin | 9.28% |
| Profit Margin | 8.54% |
| EBITDA Margin | 5.15% |
| EBIT Margin | 3.98% |
| FCF Margin | 11.23% |
Dividends & Yields
This stock pays an annual dividend of 2.50, which amounts to a dividend yield of 2.46%.
| Dividend Per Share | 2.50 |
| Dividend Yield | 2.46% |
| Dividend Growth (YoY) | -20.74% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 137.80% |
| Buyback Yield | -0.45% |
| Shareholder Yield | 2.02% |
| Earnings Yield | 2.83% |
| FCF Yield | 3.72% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on August 1, 2024. It was a forward split with a ratio of 1.1499016.
| Last Split Date | Aug 1, 2024 |
| Split Type | Forward |
| Split Ratio | 1.1499016 |
Scores
Onyx Healthcare has an Altman Z-Score of 6.37 and a Piotroski F-Score of 6.
| Altman Z-Score | 6.37 |
| Piotroski F-Score | 6 |